Senile degeneration and cognitive impairment in chronic schizophrenia

American Journal of Psychiatry

Volumn 155, Issue 11, 1998, Pages 1536-1543

  Dwork, Andrew J ^a   Susser, Ezra S ^b   Keilp, John ^b   Waniek, Cristina ^b   Liu, Dongmei ^b   Kaufman, Mavis ^b   Zemishlany, Zvi ^b   Prohovnik, Isak ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AFFECTIVE NEUROSIS; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; SENILE DEMENTIA;

EID: 0031729306     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.155.11.1536     Document Type: Article

References (63)

1. Johnstone EC, Crow TJ, Frith CD, Stevens M, Krel L, Husband J: The dementia of dementia praecox. Acta Psychiatr Scand 1978; 357:305-324
2. Gold JM, Weinberger DR: Cognitive deficits and the neurobiology of schizophrenia. Curr Opin Neurobiol 1995; 5:225-230
3. Harvey PD, Lombardi J, Kincaid MM, Parrella M, White L, Powchik P, Davidson M: Cognitive functioning in chronically hospitalized schizophrenic patients: age-related changes and age disorientation as a predictor of impairment. Schizophr Res 1995; 17:15-24
4. Harvey PD, White L, Parrella M, Putnam KM, Kincaid MM, Powchik P, Mohs RC, Davidson M: The longitudinal stability of cognitive impairment in schizophrenia: Mini-Mental State scores at one- and two-year follow-ups in geriatric in-patients. Br J Psychiatry 1995; 166:630-633
5. Davidson M, Harvey PD, Powchik P, Parrella M, White L, Knobler HY, Losonczy MF, Keefe RSE, Katz S, Frecska E: Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry 1995; 152:197-207
6. Jellinger K: Neuromorphological background of pathochemical studies in major psychoses, in Pathochemical Markers in Major Psychoses. Edited by Beckmann H, Biederer P, Berlin, Springer Verlag, 1985, pp 1-23
7. Buhl L, Bojsen-Møller M: Frequency of Alzheimer's disease in a postmortem study of psychiatric patients. Dan Med Bull 1988; 35:288-290
8. Bruton CJ, Crow TJ, Frith CD, Johnstone EC, Owens DGC, Roberts GW: Schizophrenia and the brain: a prospective clinico-neuropathological study. Psychol Med 1990; 20:285-304
9. Prohovnik I, Dwork AJ, Kaufman MA, Willson N: Alzheimer-type neuropathology in elderly schizophrenia. Schizophr Bull 1993; 19:805-816
10. Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davis KL: Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch Gen Psychiatry 1998; 55:205-211
11. Baldessarini RJ, Hegarty JD, Bird ED, Benes FM: Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia. Am J Psychiatry 1997; 154:861-863; correction, 154:1180
12. Gurland BJ: The borderlands of dementia: the influence of sociocultural characteristics on rates of dementia occurring in the senium, in Clinical Aspects of Alzheimer's Disease and Senile Dementia: Aging, vol 15. Edited by Miller NE, Cohen GD. New York, Raven Press, 1981, pp 61-84
13. Zhang MY, Katzman R, Salmon D, Jin H, Cai G, Wang Z, Qu G, Grant I, Tu E, Levy P, Klauber MR, Liu WT: The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 1990; 27: 428-437
14. Katzman R: Education and the prevalence of dementia and Alzheimer's disease. Neurology 1993; 43:13-20
15. Stern Y, Alexander GE, Prohovnik I, Stricks L, Link B, Lennon MC, Mayeux R: Relationship between lifetime occupation and parietal flow: implications for a reserve against Alzheimer's disease pathology. Neurology 1995; 45:55-60
16. Keilp JG, Waniek C, Goldman RG, Zemishlany Z, Alexander GE, Gibbon M, Wu A, Susser E, Prohovnik I: Reliability of post-mortem chart diagnoses of schizophrenia and dementia. Schizophr Res 1995; 17:221-228
17. Khachaturian ZS: Diagnosis of Alzheimer's disease. Arch Neurol 1985; 42:1097-1105
18. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41:479-486
19. Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SH, Aronson MK: Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1992; 13:179-189
20. Morris JC, Storandt M, McKeel DW Jr, Rubin EH, Price JL, Grant EA, Berg L: Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996; 46:707-719
21. Ksiezak-Reding H, Davies P, Yen S-H: Alz 50, a monoclonal antibody to Alzheimer's disease antigen, cross-reacts with tau proteins from bovine and normal human brain. J Biol Chem 1988; 263:7943-7947
22. Yen S-H, Crowe A, Dickson DW: Monoclonal antibodies to Alzheimer neurofibrillary tangles, 1: identification of polypeptides. Am J Pathol 1985; 120:282-291
23. Dwork AJ, Liu D, Kaufman MA, Prohovnik I: Archival, formalin-fixed tissue: its use in the study of Alzheimer's type changes. Clin Neuropathol 1998; 17:45-49
24. Morris JC, McKeel DW Jr, Storandt M, Rubin EH, Price JL, Grant EA, Ball MJ, Berg L: Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991; 41:469-478
25. Berg L, McKeel DW Jr, Miller JP, Baty J, Morris JC: Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older. Arch Neurol 1993; 50:349-358
26. El-Mallakh RS, Kirch DG, Shelton R, Fan K-J, Pezeshkpour G, Kanhouwa S, Wyatt RJ, Kleinman JE: The nucleus basalis of Meynert, senile plaques, and intellectual impairment in schizophrenia. J Neuropsychiatry Clin Neurosci 1991; 3:383-386
27. Arnold SE, Trojanowski JQ, Gur RE, Blackwell P, Han LY, Choi C: Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch Gen Psychiatry 1998; 55:225-232
28. Wisniewski HM, Wen GY, Kim KS: Comparison of four staining methods on the detection of neuritic plaques. Acta Neuropathol (Berl) 1989; 78:22-27
29. Harvey PD, Powchik P, Mohs RC, Davidson M: Memory functions in geriatric chronic schizophrenic patients: a neuropsychological study. J Neuropsychiatry Clin Neurosci 1995; 7: 207-212
30. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A: Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988; 23: 138-144
31. DeKosky ST, Scheff SW: Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 1990; 27:457-464
32. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R: Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30:572-580
33. Saykin AJ, Gur RC, Gur RE, Mozley PD, Mozley LH, Resnick SM, Kester DB, Stafiniak P: Neuropsychological function in schizophrenia: selective impairment in memory and learning. Arch Gen Psychiatry 1991; 48:618-624
34. Jones P, Rodgers B, Murray R, Marmot M: Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994; 344:1398-1402
35. Haroutunian V, Davidson M, Kanof PD, Perl DP, Powchik P, Losonczy M, McCrystal J, Purohit DP, Bierer LM, Davis KL: Cortical cholinergic markers in schizophrenia. Schizophr Res 1994; 12:137-144
36. Eastwood SL, Harrison PJ: Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 1995; 69:339-343
37. Eastwood SL, Burnet PWJ, Harrison PJ: Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 1995; 66:309-319
38. Browning MD, Dudek EM, Rapier JL, Leonard S, Freedman R: Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry 1993; 34:529-535
39. Thompson PM, Sower AC, Perrone-Bizzozero MI: Altered levels of the synaptosomal associated protein SNAP 25 in schizophrenia. Biol Psychiatry 1998; 43:239-243
40. Gabriel SM, Haroutunian V, Powchik P, Honer W, Davidson M, Davies P, Davis K: Increased concentrations of presynaptic proteins in the cingulate cortex of schizophrenics. Arch Gen Psychiatry 1997; 54:559-566
41. Honer WG, Falkai P, Young C, Wang T, Xie J, Bonner J, Hu L, Boulianne GL, Luo Z, Trimble WS: Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neuroscience 1997; 78:99-110
42. Young CE, Arima K, Xie J, Hu L, Beach TG, Falkai P, Honer WG: SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cerebral Cortex 1998; 8:261-268
43. Arnold SE, Lee VA-Y, Gur RE, Trojanowski JQ: Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci USA 1991; 88:10850-10854
44. Cotter D, Kerwin R, Doshi B, Martin CS, Everall IP: Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia. Brain Res 1997; 765:238-246
45. Dwork AJ, Rosoklija G: Loss of subicular map2 immunoreactivity in schizophrenia is not associated with gliosis. Abstracts of the Society for Neuroscience 1997; 23:2201
46. Arnold SE, Franz BR, Gur RC, Gur RE, Shapiro RM, Moberg PJ, Trojanowski JQ: Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry 1995; 152:738-748
47. Benes FM, Sorensen I, Bird ED: Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull 1991; 17:597-608
48. Rajkowska G, Selemon LD, Goldman-Rakic PS: Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 1998; 55:215-224
49. Selemon LD, Rajakowska G, Goldman-Rakic PS: Abnormally high neuron density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 1995; 52:805-818
50. Albert ML, Feldman RG, Willis AL: The "subcortical dementia" of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974; 37:121-130
51. Knopman DS, Mastri AR, Frey WH II, Sung JH, Rustan T: Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology 1990; 40:251-256
52. Torack RM, Morris JC: Mesolimbocortical dementia: a clinico-pathologic case study of a putative disorder. Arch Neurol 1986; 43:1074-1078
53. Gibb WRG, Luthert PH, Marsden CD: Corticobasal degeneration. Brain 1989; 112:1171-1192
54. McKeith LG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996; 47:1113-1124
55. Stern Y, Tetrud JW, Martin WR, Kutner SJ, Langston JW: Cognitive change following MPTP exposure. Neurology 1990; 40: 261-264
56. Weinberger DR: The pathogenesis of schizophrenia: a neurodevelopmental theory, in Handbook of Schizophrenia, vol 1: The Neurology of Schizophrenia. Edited by Nasrallah HA, Weinberger DR. Amsterdam, Elsevier, 1986, pp 397-406
57. Grace AA: Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 1991; 41:1-24
58. Goldstein M, Deutch AY: Dopaminergic mechanisms in the pathogenesis of schizophrenia. FASEB J 1992; 6:2413-2421
59. Wyatt RJ, Karoum F, Casanova MF: Decreased DOPAC in the anterior cingulate cortex of individuals with schizophrenia. Biol Psychiatry 1995; 38:4-12
60. Akil M, Lewis DA: Reduced dopamine innervation of the pre-frontal cortex in schizophrenia. Abstracts of the Society for Neuroscience 1996; 22:1679
61. Benes F, Todtenkopf MS, Taylor JB: Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain. Synapse 1997; 25:80-92
62. Côté LJ, Kremzner LT: Biochemical changes in normal aging in human brain, in The Dementias. Edited by Mayeux R, Rosen WG. New York, Raven Press, 1983, pp 19-30
63. Mann DMA, Yates PO: Lipoprotein pigments - their relationship to aging in the human nervous system, II: the melanin content of pigmented nerve cells. Brain 1974; 97:489-498